NEUROLOGY 2004;62:2098-2100
© 2004 American Academy of Neurology
Brief Communications
Patterns of cannabis use among patients with multiple sclerosis
A. J. Clark, MD FRCPC,
M. A. Ware, MBBS MRCP(UK),
E. Yazer, BSc,
T. J. Murray, FRCPC and
M. E. Lynch, MD FRCPC
From Dalhousie University (Drs. Clark, Murray, and Lynch, E. Yazer), Halifax, Nova Scotia, Canada; and McGill University (Dr. Ware), Montreal, Quebec, Canada.
Address correspondence and reprint requests to Dr. Mark A. Ware, E19.145, Montreal General Hospital, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada; e-mail: mark.ware{at}muhc.mcgill.ca
To estimate the patterns and prevalence of cannabis use among patients with multiple sclerosis (MS), 220 patients were surveyed in Halifax, Nova Scotia. Seventy-two subjects (36%) reported ever having used cannabis for any purpose; 29 respondents (14%) reported continuing use of cannabis for symptom treatment. Medical cannabis use was associated with male gender, tobacco use, and recreational cannabis use. The symptoms reported by medical cannabis users to be most effectively relieved were stress, sleep, mood, stiffness/spasm, and pain.
Received November 11, 2003.
Accepted in final form March 2, 2004.
See also pages 1924 and 2095
J.C. and M.W. contributed equally to this manuscript.
This article has been cited by other articles:

|
 |

|
 |
 
P. A. Arnett
Cannabis bliss?: Perhaps not?
Neurology,
July 15, 2008;
71(3):
160 - 161.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ghaffar and A. Feinstein
Multiple sclerosis and cannabis: A cognitive and psychiatric study
Neurology,
July 15, 2008;
71(3):
164 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Ross, I. Napier, and M. Connor
Inhibition of Recombinant Human T-type Calcium Channels by {Delta}9-Tetrahydrocannabinol and Cannabidiol
J. Biol. Chem.,
June 6, 2008;
283(23):
16124 - 16134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Woolmore, M. Stone, S. Holley, P. Jenkinson, A. Ike, P. Jones, A. Fryer, R. Strange, R. Stephens, D. Langdon, et al.
Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis
Multiple Sclerosis,
March 1, 2008;
14(2):
177 - 182.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Papathanasopoulos, L. Messinis, E. Lyros, A. Kastellakis, and G. Panagis
Multiple Sclerosis, Cannabinoids, and Cognition
J Neuropsychiatry Clin Neurosci,
February 1, 2008;
20(1):
36 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bowling
Cannabinoids in MS--are we any closer to knowing how best to use them?
Multiple Sclerosis,
September 1, 2006;
12(5):
523 - 525.
[PDF]
|
 |
|

|
 |

|
 |
 
M S Chong, K Wolff, K Wise, C Tanton, A Winstock, and E Silber
Cannabis use in patients with multiple sclerosis
Multiple Sclerosis,
September 1, 2006;
12(5):
646 - 651.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Sirven and A. T. Berg
Marijuana as a treatment for epilepsy and multiple sclerosis?: A "grass roots" movement
Neurology,
June 8, 2004;
62(11):
1924 - 1925.
[Full Text]
[PDF]
|
 |
|
|